Vgkc is dead: long live lgi1- and caspr2-antibodies. intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
Main Authors: | Lang, B, Maddison, P, Dettmann, I, Adcock, J, Buckley, C, Leite, I, Vincent, A, Komorowski, L, Waters, P, Irani, S |
---|---|
Format: | Conference item |
Language: | English |
Published: |
BMJ Publishing Group
2017
|
Similar Items
-
Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
by: Michael, S, et al.
Published: (2020) -
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
by: Lang, B, et al.
Published: (2017) -
LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
by: Binks, S, et al.
Published: (2017) -
Distinct HLA associations of LGI1 and CASPR2-antibody diseases
by: Binks, S, et al.
Published: (2018) -
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies: Evidence for relative pathogenicity
by: Lang, B, et al.
Published: (2017)